首页> 外国专利> heterodimeric Fc IL-21 heterodimeric Fc-fused IL-21 Heterodimeric Fc-fused IL-21 and Pharmaceutical Composition Comprising the Same

heterodimeric Fc IL-21 heterodimeric Fc-fused IL-21 Heterodimeric Fc-fused IL-21 and Pharmaceutical Composition Comprising the Same

机译:异二聚体Fc IL-21异二聚体Fc融合的IL-21异二聚体Fc融合的IL-21及其药物组合物

摘要

The present invention encompasses a fusion protein comprising a first Fc region and a second Fc region of a heavy chain constant region pair of an antibody (immunoglobulin), wherein at least one of the N-terminal or C-terminal ends of the first Fc region and / Wherein the first Fc region and the second Fc region are mutated in such a manner that the formation of a heterodimer is promoted in the heterodimeric Fc-fused protein wherein IL-21 is bound to the IL-21, And a heterodimeric Fc-fused protein and a heterologous duplex-fusion protein. When the antibody heavy chain constant region heterologous duplex-fusion protein according to the present invention is used, the half-life of the IL-21 contained in the heterologous duplex-fusion protein can be remarkably increased.
机译:本发明包括融合蛋白,其包含抗体(免疫球蛋白)的重链恒定区对的第一Fc区和第二Fc区,其中第一Fc区的N-末端或C-末端中的至少一个和/或其中第一Fc区和第二Fc区以这样的方式突变,使得在其中IL-21结合至IL-21的异二聚Fc融合蛋白中促进异二聚体的形成,以及异二聚Fc-融合蛋白和异源双链融合蛋白。当使用根据本发明的抗体重链恒定区异源双链融合蛋白时,包含在异源双链融合蛋白中的IL-21的半衰期可以显着增加。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号